Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Laurie Gaspar

Concepts (495)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms
100
2022
975
8.160
Why?
Lung Neoplasms
91
2023
2172
6.250
Why?
Carcinoma, Non-Small-Cell Lung
54
2022
995
4.920
Why?
Radiosurgery
44
2022
294
4.770
Why?
Cranial Irradiation
20
2022
63
3.250
Why?
Small Cell Lung Carcinoma
11
2023
70
3.140
Why?
Combined Modality Therapy
62
2022
1188
1.460
Why?
Radiation Pneumonitis
5
2021
25
1.460
Why?
Radiotherapy, Intensity-Modulated
9
2018
128
1.410
Why?
Antineoplastic Combined Chemotherapy Protocols
30
2023
1401
1.410
Why?
Carcinoma, Small Cell
8
2007
159
1.340
Why?
Practice Guidelines as Topic
14
2021
1524
1.330
Why?
Neoplasm Staging
39
2020
1216
1.290
Why?
Radiotherapy Dosage
39
2023
245
1.240
Why?
Chemoradiotherapy
8
2020
196
1.200
Why?
Brachytherapy
12
2017
94
1.120
Why?
Glioblastoma
18
2016
252
1.090
Why?
Neoplasm Recurrence, Local
21
2017
845
1.080
Why?
Radiotherapy Planning, Computer-Assisted
11
2021
124
1.060
Why?
Radiation Oncology
12
2022
73
1.020
Why?
Liver Neoplasms
8
2009
452
0.970
Why?
Glioma
15
2015
293
0.910
Why?
Adenocarcinoma
13
2022
818
0.880
Why?
Aged
102
2020
20243
0.880
Why?
Esophageal Neoplasms
9
2008
237
0.880
Why?
Humans
222
2023
117481
0.840
Why?
Prognosis
45
2022
3540
0.820
Why?
Survival Rate
31
2018
1807
0.810
Why?
Middle Aged
118
2020
28654
0.810
Why?
Radiotherapy, Conformal
8
2017
67
0.780
Why?
Clinical Trials as Topic
18
2018
998
0.760
Why?
Radiotherapy, Adjuvant
16
2022
186
0.750
Why?
Radiotherapy
14
2017
191
0.740
Why?
Neurosurgeons
1
2019
12
0.740
Why?
Dacarbazine
9
2016
105
0.730
Why?
Four-Dimensional Computed Tomography
6
2021
27
0.700
Why?
Evidence-Based Medicine
10
2021
724
0.690
Why?
Oncologists
1
2018
28
0.660
Why?
Clinical Decision-Making
3
2021
286
0.630
Why?
Male
128
2022
60409
0.630
Why?
Patient Selection
10
2019
698
0.630
Why?
Aged, 80 and over
45
2020
6794
0.620
Why?
Cisplatin
18
2021
270
0.620
Why?
Female
131
2020
63228
0.620
Why?
Carcinoma, Squamous Cell
10
2017
597
0.600
Why?
Antineoplastic Agents, Alkylating
8
2016
65
0.590
Why?
Physician's Role
1
2018
214
0.580
Why?
Antineoplastic Agents
20
2017
2015
0.570
Why?
Induction Chemotherapy
2
2013
56
0.550
Why?
Adult
90
2020
32104
0.550
Why?
Treatment Outcome
36
2021
9333
0.500
Why?
Receptor Protein-Tyrosine Kinases
5
2017
267
0.490
Why?
Survival Analysis
24
2020
1359
0.480
Why?
Physician-Patient Relations
1
2018
506
0.480
Why?
Etoposide
12
2021
160
0.470
Why?
Retrospective Studies
40
2022
12318
0.450
Why?
Pro-Opiomelanocortin
7
1989
23
0.440
Why?
Pneumonectomy
2
2015
121
0.440
Why?
Astrocytoma
9
2014
108
0.420
Why?
Medical Oncology
7
2021
219
0.380
Why?
Melanoma
5
2018
695
0.380
Why?
Whole-Body Irradiation
1
2009
77
0.380
Why?
Chemotherapy, Adjuvant
12
2017
341
0.370
Why?
Societies, Medical
7
2021
754
0.370
Why?
Pulmonary Ventilation
4
2021
73
0.370
Why?
Protein Kinase Inhibitors
4
2021
862
0.370
Why?
Guidelines as Topic
2
2020
282
0.370
Why?
Karnofsky Performance Status
11
2020
39
0.370
Why?
Guideline Adherence
4
2018
538
0.360
Why?
ErbB Receptors
8
2022
568
0.360
Why?
Breast Neoplasms
9
2020
1926
0.360
Why?
Dose-Response Relationship, Radiation
11
2019
129
0.350
Why?
Lung
9
2021
3641
0.350
Why?
Quinazolines
6
2014
246
0.340
Why?
Iodine Radioisotopes
6
2006
124
0.340
Why?
Re-Irradiation
2
2018
8
0.330
Why?
Controlled Clinical Trials as Topic
1
2007
29
0.330
Why?
Neoplasm Metastasis
8
2019
593
0.330
Why?
Disease Progression
13
2018
2542
0.330
Why?
Radiopharmaceuticals
5
2014
170
0.320
Why?
Anticonvulsants
2
2019
188
0.310
Why?
Follow-Up Studies
22
2018
4914
0.310
Why?
Tumor Burden
9
2017
283
0.310
Why?
Biomarkers, Tumor
6
2021
1048
0.300
Why?
Prospective Studies
22
2018
6420
0.290
Why?
Tomography, X-Ray Computed
10
2018
2463
0.290
Why?
Paclitaxel
5
2011
197
0.290
Why?
Proto-Oncogene Proteins B-raf
2
2017
195
0.280
Why?
Carcinoma, Hepatocellular
2
2005
184
0.280
Why?
Spinal Cord
4
2018
400
0.270
Why?
Steroids
2
2019
142
0.260
Why?
Taxoids
5
2015
95
0.260
Why?
Carcinoma
1
2006
205
0.260
Why?
Lymphatic Metastasis
3
2017
302
0.250
Why?
Magnetic Resonance Imaging
9
2019
3213
0.250
Why?
Central Nervous System
2
2017
262
0.250
Why?
Carcinoma, Renal Cell
3
2018
173
0.250
Why?
Gastrointestinal Neoplasms
3
2019
57
0.250
Why?
Randomized Controlled Trials as Topic
7
2021
1205
0.240
Why?
Neoplasms
6
2020
2137
0.220
Why?
Positron Emission Tomography Computed Tomography
2
2020
66
0.220
Why?
Necrosis
3
2019
232
0.220
Why?
Medical Illustration
2
2012
10
0.220
Why?
Radiography
8
2014
860
0.220
Why?
Organs at Risk
2
2012
30
0.220
Why?
Brachial Plexus
2
2012
28
0.220
Why?
Ribs
2
2012
35
0.220
Why?
Esophagectomy
1
2002
70
0.210
Why?
Professional Staff Committees
4
2001
15
0.210
Why?
Oligodendroglioma
4
2014
14
0.210
Why?
Testicular Neoplasms
1
2022
84
0.210
Why?
Mutation
4
2021
3406
0.200
Why?
Research Design
7
2018
969
0.190
Why?
Thymus Neoplasms
2
2017
21
0.190
Why?
Thymoma
2
2017
32
0.190
Why?
Proportional Hazards Models
8
2020
1200
0.190
Why?
Peptide Fragments
4
1989
718
0.190
Why?
Consolidation Chemotherapy
1
2019
12
0.190
Why?
Esophagus
2
2012
239
0.190
Why?
Meningeal Neoplasms
3
2017
78
0.180
Why?
Maximum Tolerated Dose
6
2010
189
0.180
Why?
Metalloporphyrins
3
2011
109
0.180
Why?
Congresses as Topic
2
2019
205
0.180
Why?
Radiation Injuries
5
2015
137
0.180
Why?
Watchful Waiting
1
2019
57
0.180
Why?
Expert Testimony
1
2019
55
0.180
Why?
Aquaporin 4
1
2019
79
0.180
Why?
Time Factors
10
2019
6905
0.180
Why?
Intracranial Arteriovenous Malformations
2
1995
23
0.170
Why?
Gray Matter
1
2019
68
0.170
Why?
CTLA-4 Antigen
1
2018
78
0.170
Why?
Spinal Neoplasms
1
2018
28
0.170
Why?
Cognition
4
2013
1019
0.170
Why?
Quality of Life
5
2013
2351
0.170
Why?
Carboplatin
4
2011
142
0.160
Why?
Intersectoral Collaboration
1
2018
60
0.160
Why?
Endpoint Determination
1
2018
67
0.160
Why?
Kidney Neoplasms
3
2018
342
0.160
Why?
Pituitary Neoplasms
5
1994
154
0.160
Why?
Treatment Failure
5
2014
339
0.160
Why?
Professional Competence
1
2018
100
0.160
Why?
Receptor, ErbB-2
5
2020
318
0.160
Why?
Mortality
1
2019
317
0.160
Why?
Genes, ras
1
2017
97
0.160
Why?
Antineoplastic Agents, Immunological
1
2019
153
0.160
Why?
Decision Trees
1
1997
88
0.160
Why?
Triazines
2
2009
40
0.160
Why?
Proto-Oncogene Proteins c-kit
1
2017
63
0.160
Why?
Fluorouracil
6
2004
150
0.150
Why?
Interdisciplinary Communication
1
2018
201
0.150
Why?
Salvage Therapy
4
2017
136
0.150
Why?
Programmed Cell Death 1 Receptor
1
2018
188
0.150
Why?
Hemangioma, Cavernous
2
1993
17
0.150
Why?
Cohort Studies
7
2019
5106
0.150
Why?
Brain
5
2019
2697
0.150
Why?
Pulmonary Atelectasis
1
2015
15
0.150
Why?
Patient Preference
1
2018
174
0.140
Why?
Antibodies
1
2018
405
0.140
Why?
Accreditation
2
2013
96
0.140
Why?
United States
13
2022
12756
0.140
Why?
Radiation-Sensitizing Agents
5
2009
37
0.140
Why?
Age Factors
8
2017
3221
0.140
Why?
Postoperative Care
1
2017
229
0.140
Why?
Adrenal Cortex Hormones
1
2019
517
0.140
Why?
Central Nervous System Neoplasms
1
2017
126
0.140
Why?
Medically Underserved Area
1
2016
99
0.140
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2015
119
0.130
Why?
Antineoplastic Agents, Phytogenic
2
2006
194
0.130
Why?
Triple Negative Breast Neoplasms
1
2017
159
0.130
Why?
Carmustine
7
2010
51
0.130
Why?
Camptothecin
2
2011
95
0.130
Why?
Perfusion Imaging
1
2014
52
0.130
Why?
Cerebellar Neoplasms
2
1996
126
0.130
Why?
Fibrosarcoma
1
1993
22
0.130
Why?
Lymphoma, Large-Cell, Anaplastic
1
2014
20
0.130
Why?
Adolescent
22
2017
18875
0.130
Why?
Medulloblastoma
2
1996
171
0.130
Why?
Risk Assessment
3
2021
3206
0.120
Why?
Nelson Syndrome
4
1987
4
0.120
Why?
Contraindications
2
2008
93
0.120
Why?
Receptors, Progesterone
4
2020
324
0.120
Why?
Pyrazoles
2
2014
401
0.120
Why?
Analysis of Variance
5
2014
1454
0.120
Why?
Gene Expression Regulation, Neoplastic
1
2019
1193
0.120
Why?
Respiratory Function Tests
1
2015
595
0.120
Why?
Pyridines
2
2014
471
0.120
Why?
Disease-Free Survival
6
2014
676
0.120
Why?
Kaplan-Meier Estimate
5
2019
897
0.120
Why?
beta-Endorphin
3
1989
7
0.120
Why?
Pancreatic Neoplasms
1
2000
753
0.110
Why?
Radiotherapy, High-Energy
4
2000
12
0.110
Why?
Particle Accelerators
1
1991
9
0.110
Why?
Bone Neoplasms
3
2007
204
0.110
Why?
Adrenocorticotropic Hormone
3
1989
160
0.110
Why?
Radiation Protection
2
2009
37
0.110
Why?
Young Adult
8
2017
11069
0.110
Why?
Hyperthermia, Induced
1
1992
70
0.100
Why?
Databases, Factual
5
2017
1145
0.100
Why?
Forced Expiratory Volume
2
2015
597
0.100
Why?
Quality Assurance, Health Care
3
2009
355
0.100
Why?
Bevacizumab
3
2015
122
0.100
Why?
Technology, Radiologic
1
2010
6
0.100
Why?
Radiotherapy, Computer-Assisted
1
2010
13
0.100
Why?
MEDLINE
1
2009
26
0.100
Why?
Spine
1
1991
137
0.100
Why?
Clinical Trials, Phase II as Topic
2
2002
61
0.100
Why?
Neurosurgery
1
2009
22
0.100
Why?
Adenoma
4
1994
184
0.100
Why?
Palliative Care
5
2018
638
0.090
Why?
Adrenal Medulla
1
1989
8
0.090
Why?
Risk Factors
7
2021
9124
0.090
Why?
Neurotensin
1
1989
12
0.090
Why?
Drug Therapy
1
2009
74
0.090
Why?
Piperidines
1
2010
174
0.090
Why?
Severity of Illness Index
2
2008
2877
0.090
Why?
Multivariate Analysis
6
2020
1585
0.090
Why?
Ependymoma
2
2009
163
0.090
Why?
Fractures, Spontaneous
1
1988
15
0.090
Why?
Meta-Analysis as Topic
1
2009
151
0.090
Why?
Catheter Ablation
1
2012
341
0.090
Why?
Education, Medical, Graduate
1
2013
418
0.090
Why?
Esophageal Fistula
2
2000
20
0.090
Why?
Pheochromocytoma
1
1989
52
0.090
Why?
Liver
2
2008
1852
0.090
Why?
Radionuclide Imaging
1
2008
137
0.090
Why?
Equipment Failure Analysis
1
2009
135
0.090
Why?
Respiratory Mechanics
1
2008
79
0.090
Why?
Imaging, Three-Dimensional
2
2010
556
0.090
Why?
Adrenal Gland Neoplasms
1
1989
78
0.090
Why?
Humeral Fractures
1
1988
53
0.090
Why?
Femoral Fractures
1
1988
75
0.090
Why?
Craniopharyngioma
1
2009
71
0.090
Why?
Lymph Node Excision
1
2009
154
0.090
Why?
Positron-Emission Tomography
2
2008
273
0.080
Why?
Surveys and Questionnaires
2
2018
4847
0.080
Why?
Chromatography, Gel
4
1989
132
0.080
Why?
Kidney
2
2005
1236
0.080
Why?
Radioimmunoassay
4
1989
179
0.080
Why?
Uterine Cervical Neoplasms
1
1989
205
0.080
Why?
Statistics, Nonparametric
2
2018
444
0.080
Why?
Seizures
1
2009
344
0.080
Why?
Biomedical Research
2
2009
598
0.070
Why?
Clinical Competence
1
2013
946
0.070
Why?
Whole Body Imaging
1
2006
24
0.070
Why?
Neoplasm Grading
2
2020
253
0.070
Why?
Vascular Diseases
1
2009
238
0.070
Why?
Hepatitis B, Chronic
1
2005
18
0.070
Why?
Genetic Markers
2
2017
349
0.070
Why?
Hemoglobins
1
2007
282
0.070
Why?
Strontium Radioisotopes
2
2006
3
0.070
Why?
Diagnostic Imaging
3
2009
292
0.070
Why?
Antiemetics
1
2005
33
0.070
Why?
Immunotherapy
2
2022
476
0.070
Why?
Databases as Topic
1
2005
60
0.070
Why?
Drug Administration Schedule
3
2014
780
0.070
Why?
Pulmonary Disease, Chronic Obstructive
1
2015
1418
0.070
Why?
Linear Models
3
2017
873
0.070
Why?
Vascular Endothelial Growth Factor A
1
2008
507
0.070
Why?
Anticoagulants
1
2009
542
0.070
Why?
Physicians
1
2013
771
0.070
Why?
Gene Rearrangement
2
2018
158
0.070
Why?
Feasibility Studies
3
2011
766
0.070
Why?
Pituitary Hormones
1
1984
17
0.070
Why?
Peptides
3
1985
874
0.070
Why?
Consensus
2
2021
506
0.070
Why?
Delivery of Health Care
1
2012
815
0.070
Why?
Body Fluids
1
1985
66
0.070
Why?
Dexamethasone
3
2012
304
0.070
Why?
Organ Size
1
2005
492
0.070
Why?
Retreatment
3
2012
70
0.070
Why?
Practice Patterns, Physicians'
1
2013
1228
0.060
Why?
Age Distribution
1
2005
382
0.060
Why?
Sex Distribution
1
2005
390
0.060
Why?
Liver Cirrhosis
1
2005
223
0.060
Why?
Erlotinib Hydrochloride
2
2014
69
0.060
Why?
Cognition Disorders
2
2010
580
0.060
Why?
Hepatitis C, Chronic
1
2005
152
0.060
Why?
Propionates
1
2003
34
0.060
Why?
Regression Analysis
2
2017
1073
0.060
Why?
Preoperative Care
1
2005
323
0.060
Why?
Internship and Residency
1
2013
1024
0.060
Why?
Drug-Related Side Effects and Adverse Reactions
1
2006
234
0.060
Why?
Aniline Compounds
1
2003
67
0.060
Why?
Chromatography, Affinity
3
1989
92
0.060
Why?
Societies
1
2022
42
0.060
Why?
Clinical Trials, Phase III as Topic
2
2004
83
0.060
Why?
Pterygium
1
2000
4
0.050
Why?
Organizational Objectives
4
2001
71
0.050
Why?
Algorithms
2
2017
1549
0.050
Why?
B7-H1 Antigen
1
2022
135
0.050
Why?
Ontario
2
2017
56
0.050
Why?
Esophagoscopy
1
2002
192
0.050
Why?
Vincristine
2
2010
106
0.050
Why?
Reproducibility of Results
2
2015
2942
0.050
Why?
Neurologic Examination
1
2000
125
0.050
Why?
BRCA1 Protein
1
2020
53
0.050
Why?
Carcinoma, Bronchogenic
1
1999
16
0.050
Why?
Spinal Cord Neoplasms
1
1999
35
0.050
Why?
Carcinoma, Large Cell
1
1999
15
0.050
Why?
Receptors, Estrogen
2
2013
387
0.050
Why?
Reoperation
2
2012
553
0.040
Why?
Medical Records
2
2010
176
0.040
Why?
Neuropsychological Tests
3
2013
1115
0.040
Why?
Liver Transplantation
1
2005
798
0.040
Why?
Urinary Bladder Neoplasms
1
2001
194
0.040
Why?
Estrogens
1
2020
306
0.040
Why?
Child, Preschool
7
2009
9699
0.040
Why?
Thoracic Vertebrae
1
2018
72
0.040
Why?
Iridium Radioisotopes
1
1997
6
0.040
Why?
Aziridines
2
1994
4
0.040
Why?
Epidemiologic Methods
1
2017
70
0.040
Why?
Precision Medicine
1
2020
291
0.040
Why?
Clinical Trials, Phase I as Topic
1
1997
53
0.040
Why?
Colorado
3
2014
4401
0.040
Why?
Molecular Weight
2
1989
350
0.040
Why?
Biopsy, Needle
1
2017
193
0.040
Why?
Neutropenia
2
2009
128
0.040
Why?
Benzoquinones
2
1994
46
0.040
Why?
Propensity Score
1
2018
251
0.040
Why?
Esophagitis
2
2009
67
0.040
Why?
Skin Neoplasms
2
2017
808
0.040
Why?
Supratentorial Neoplasms
1
1996
19
0.040
Why?
Memory Disorders
2
2010
181
0.040
Why?
Respiration
1
2017
196
0.040
Why?
Meningioma
1
1997
69
0.040
Why?
Estrogen Receptor alpha
1
2017
117
0.040
Why?
Odds Ratio
1
1999
1038
0.040
Why?
Heart
1
2020
661
0.040
Why?
Pilot Projects
3
2015
1438
0.040
Why?
Sex Factors
2
2014
1921
0.040
Why?
Cerebral Angiography
1
1995
90
0.040
Why?
Technetium Tc 99m Pentetate
1
2014
6
0.030
Why?
Ventilation-Perfusion Ratio
1
2014
14
0.030
Why?
Nuclear Medicine
1
2014
7
0.030
Why?
Marital Status
1
2014
53
0.030
Why?
Child
9
2009
18613
0.030
Why?
Forecasting
3
2001
371
0.030
Why?
Vital Capacity
1
2015
277
0.030
Why?
Texas
1
2014
178
0.030
Why?
Myocardium
1
2020
1000
0.030
Why?
Radioisotope Teletherapy
1
1993
2
0.030
Why?
Patient Safety
1
2017
310
0.030
Why?
Cobalt Radioisotopes
1
1993
6
0.030
Why?
Developing Countries
1
2016
251
0.030
Why?
Nervous System Diseases
1
1997
256
0.030
Why?
Molecular Targeted Therapy
1
2017
375
0.030
Why?
SEER Program
1
2014
198
0.030
Why?
Vimentin
1
1993
62
0.030
Why?
Radiodermatitis
1
1993
7
0.030
Why?
Spatial Analysis
1
2013
29
0.030
Why?
Radiometry
1
2013
45
0.030
Why?
Scalp
1
1993
26
0.030
Why?
Observer Variation
1
2014
326
0.030
Why?
Monte Carlo Method
1
2013
156
0.030
Why?
Prostatic Neoplasms
1
2001
977
0.030
Why?
Time
1
2013
87
0.030
Why?
Mitosis
1
1993
169
0.030
Why?
Ascorbic Acid
1
1993
112
0.030
Why?
Radiation Dosage
1
2013
146
0.030
Why?
Medical Errors
1
2013
99
0.030
Why?
Cerebral Cortex
1
1996
491
0.030
Why?
Protein-Tyrosine Kinases
1
2016
442
0.030
Why?
Remission Induction
2
2008
264
0.030
Why?
International Agencies
1
2011
34
0.030
Why?
Disease Management
1
2016
602
0.030
Why?
Electrons
1
1991
73
0.030
Why?
Breast Neoplasms, Male
1
2011
30
0.030
Why?
Diagnosis, Differential
1
2015
1405
0.030
Why?
Bronchography
1
2010
12
0.030
Why?
Fibrosis
1
2013
458
0.030
Why?
Longitudinal Studies
1
2018
2665
0.030
Why?
Infusions, Intravenous
2
2004
393
0.030
Why?
Radiology
1
2014
195
0.030
Why?
Lomustine
1
1990
12
0.030
Why?
Procarbazine
1
1990
10
0.030
Why?
Sensitivity and Specificity
1
2015
1895
0.020
Why?
Cell Nucleus
1
1993
588
0.020
Why?
Neoplasm, Residual
1
2010
93
0.020
Why?
Physics
1
2010
20
0.020
Why?
Selection Bias
1
2009
36
0.020
Why?
Clinical Trials Data Monitoring Committees
1
2009
5
0.020
Why?
Chromatin
1
1993
435
0.020
Why?
Hypophysectomy
1
1989
17
0.020
Why?
Quality Control
1
2010
154
0.020
Why?
Platinum
1
2009
38
0.020
Why?
Prevalence
1
2016
2434
0.020
Why?
Incidence
1
2016
2505
0.020
Why?
Adrenal Cortex
1
1989
35
0.020
Why?
Immunohistochemistry
1
1993
1755
0.020
Why?
Hepatic Veno-Occlusive Disease
1
2008
11
0.020
Why?
Neoplasms, Unknown Primary
1
1988
11
0.020
Why?
Bronchi
1
2010
249
0.020
Why?
Certification
1
2010
114
0.020
Why?
Liver Regeneration
1
2008
31
0.020
Why?
Polymorphism, Single Nucleotide
1
2016
1777
0.020
Why?
beta-Lipotropin
2
1985
2
0.020
Why?
Endorphins
2
1985
19
0.020
Why?
Smoking
1
2017
1654
0.020
Why?
Prostheses and Implants
1
2010
161
0.020
Why?
Infant
4
1999
8243
0.020
Why?
Anti-Inflammatory Agents
1
2012
470
0.020
Why?
Fracture Fixation, Intramedullary
1
1988
58
0.020
Why?
Motion
1
2008
98
0.020
Why?
Administration, Oral
1
2010
786
0.020
Why?
Mental Status Schedule
1
2007
38
0.020
Why?
Epinephrine
1
1989
183
0.020
Why?
Rectal Neoplasms
1
2008
112
0.020
Why?
International Cooperation
1
2008
181
0.020
Why?
Reference Values
1
1989
836
0.020
Why?
Bleomycin
1
2009
211
0.020
Why?
Creatinine
1
1989
472
0.020
Why?
Predictive Value of Tests
2
2008
1969
0.020
Why?
Genetic Predisposition to Disease
1
2016
2204
0.020
Why?
Chromatography, High Pressure Liquid
1
1989
507
0.020
Why?
Hydrocephalus
1
1987
69
0.020
Why?
California
1
2008
385
0.020
Why?
Southwestern United States
1
2006
94
0.020
Why?
Methadone
1
1987
75
0.020
Why?
DNA Repair
1
2008
189
0.020
Why?
Chromium Compounds
1
2006
2
0.020
Why?
Sodium Iodide
1
2006
4
0.020
Why?
Polycythemia Vera
1
2006
13
0.020
Why?
Pleural Effusion, Malignant
1
2006
16
0.020
Why?
Neovascularization, Pathologic
1
2008
289
0.020
Why?
Yttrium Radioisotopes
1
2006
20
0.020
Why?
Hyperthyroidism
1
2006
28
0.020
Why?
Patient Isolation
1
2006
18
0.020
Why?
Ascites
1
2006
35
0.020
Why?
Glucocorticoids
1
2010
555
0.020
Why?
DNA Damage
1
2008
372
0.020
Why?
Organometallic Compounds
1
2006
91
0.020
Why?
Lymphoma, Non-Hodgkin
1
2006
84
0.020
Why?
Chromatography
1
1985
28
0.020
Why?
Organophosphorus Compounds
1
2006
82
0.020
Why?
Concanavalin A
1
1985
81
0.020
Why?
ACTH Syndrome, Ectopic
1
1984
2
0.020
Why?
Occipital Lobe
1
2004
22
0.020
Why?
Phosphates
1
2006
176
0.020
Why?
Genomics
1
2009
533
0.020
Why?
Biotransformation
1
1984
57
0.020
Why?
Carbohydrate Metabolism
1
1984
52
0.020
Why?
Brain Edema
1
2004
61
0.020
Why?
Patient Education as Topic
1
2010
719
0.020
Why?
Recurrence
2
2000
1007
0.020
Why?
Arginine Vasopressin
1
1984
73
0.020
Why?
Thrombocytopenia
1
2006
188
0.020
Why?
Vomiting
1
2004
124
0.020
Why?
Bipolar Disorder
1
1985
207
0.020
Why?
Oils
1
1983
20
0.020
Why?
Corticotropin-Releasing Hormone
1
1984
98
0.020
Why?
Thyroid Neoplasms
1
2006
240
0.010
Why?
Motor Skills
1
2004
94
0.010
Why?
Immunologic Factors
1
2003
229
0.010
Why?
Opioid-Related Disorders
1
1987
355
0.010
Why?
Antimetabolites, Antineoplastic
1
2001
84
0.010
Why?
Pain
1
2006
797
0.010
Why?
Psychometrics
1
2004
689
0.010
Why?
Postoperative Period
1
2000
307
0.010
Why?
Thorax
1
1999
50
0.010
Why?
Michigan
1
1999
97
0.010
Why?
Antibodies, Monoclonal
1
2006
1266
0.010
Why?
Cysts
1
1999
84
0.010
Why?
Bias
1
1999
199
0.010
Why?
Apoptosis
1
2008
2572
0.010
Why?
Meninges
1
1997
34
0.010
Why?
Cross-Sectional Studies
1
2007
4621
0.010
Why?
Mercaptopurine
1
1996
18
0.010
Why?
Mitomycin
1
1996
26
0.010
Why?
Biopsy
1
1999
1068
0.010
Why?
Autoantibodies
1
1983
1290
0.010
Why?
Decision Making
1
2001
806
0.010
Why?
Cause of Death
1
1996
399
0.010
Why?
Solutions
1
1993
157
0.010
Why?
Neoplasms, Radiation-Induced
1
1993
74
0.010
Why?
Cerebral Hemorrhage
1
1993
89
0.010
Why?
Brain Injuries
1
1976
471
0.010
Why?
Computer Simulation
1
1995
922
0.010
Why?
Patient Compliance
1
1994
588
0.010
Why?
Evaluation Studies as Topic
1
1989
208
0.010
Why?
Double-Blind Method
1
1993
1690
0.010
Why?
Melanocyte-Stimulating Hormones
1
1985
3
0.000
Why?
Anti-Bacterial Agents
1
1976
1417
0.000
Why?
Lithium
1
1985
37
0.000
Why?
Postoperative Complications
1
1996
2113
0.000
Why?
Brassica
1
1983
6
0.000
Why?
Spain
1
1983
40
0.000
Why?
Drug Synergism
1
1984
349
0.000
Why?
Antigen-Antibody Complex
1
1983
95
0.000
Why?
Syndrome
1
1983
351
0.000
Why?
In Vitro Techniques
1
1984
1144
0.000
Why?
Sheep
1
1984
747
0.000
Why?
Wound Infection
1
1976
29
0.000
Why?
Skull
1
1976
147
0.000
Why?
Bacterial Infections
1
1976
220
0.000
Why?
Animals
1
1984
34332
0.000
Why?
Gaspar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)